Alignment Healthcare (ALHC) board member receives 24,868 RSU equity award

Rhea-AI Filing Summary

KONOWIECKI JOSEPH S reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. director Joseph S. Konowiecki received a grant of 24,868 restricted stock units, each representing one share of common stock. These RSUs will fully vest on the first anniversary of the grant date, provided he continues serving on the Board. He has elected to defer receipt of the underlying shares for three years, or earlier upon separation of service or a change of control. Following this award, he holds 1,081,009 shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider KONOWIECKI JOSEPH S

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	24,868	$0.00	--

Holdings After Transaction: Common Stock — 1,081,009 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KONOWIECKI JOSEPH S

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		24,868(1)	A	$0	1,081,009	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 24,868 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the first anniversary of the grant date, unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. The reporting person has elected to defer receipt of the underlying shares for three years (or, if earlier, upon separation of service or a change of control of the Company).

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Joseph S. Konowiecki	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alignment Healthcare (ALHC) report for Joseph S. Konowiecki?

Alignment Healthcare reported that director Joseph S. Konowiecki received 24,868 restricted stock units. Each unit represents one share of common stock, awarded as equity compensation, rather than an open-market purchase, under the company’s director compensation arrangements.

How many Alignment Healthcare (ALHC) shares does Joseph S. Konowiecki hold after this grant?

After the restricted stock unit grant, Joseph S. Konowiecki holds 1,081,009 Alignment Healthcare common shares directly. This total includes the impact of the 24,868-unit award reported in the Form 4 insider filing for the stated transaction date.

When do Joseph S. Konowiecki’s 24,868 Alignment Healthcare RSUs vest?

The 24,868 restricted stock units granted to Joseph S. Konowiecki will vest in full on the first anniversary of the grant date, provided he continues serving on Alignment Healthcare’s Board of Directors through that vesting date without an earlier separation.

Did Joseph S. Konowiecki buy Alignment Healthcare (ALHC) shares on the open market?

No, the filing shows a grant of 24,868 restricted stock units at a price of $0.00 per unit. This indicates an equity award or compensation grant, not an open-market purchase of Alignment Healthcare common stock by the director.

Has Joseph S. Konowiecki deferred receipt of his Alignment Healthcare RSU shares?

Yes, he elected to defer receipt of the shares underlying the 24,868 restricted stock units for three years. The shares may be received earlier if he separates from service or if a change of control of Alignment Healthcare occurs before that deferral period ends.

What does the Form 4 reveal about derivative or option positions for ALHC?

The Form 4 transaction relates solely to 24,868 restricted stock units tied to Alignment Healthcare common stock. The derivative summary section in the data is empty, indicating no additional derivative transactions were reported in this particular filing for the director.